MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study

    D. Martins, A. Lees, H. Reichmann, J-F. Rocha (Coronado, Portugal)

    Objective: This study aims to evaluate changes in Parkinson’s disease (PD) progression scales in patients with PD and motor fluctuations (MF) treated with once-daily opicapone…
  • 2023 International Congress

    Beta is jumping the queue: Temporal overlap of beta desynchronization and synchronization during rapid movement changes

    L. Winkler, M. Butz, A. Sharma, J. Vesper, A. Schnitzler, P. Fischer, J. Hirschmann (Düsseldorf, Germany)

    Objective: Movement initiation and termination are often studied in isolation. Here we shed light on the neural processes underlying rapid changes of ongoing movements, where…
  • 2023 International Congress

    Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

    J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)

    Objective: To assess current practices for timing of physical therapy (PT) in Parkinson’s disease (PD). Background: Most persons with Parkinson disease (PD) face increasing mobility…
  • 2023 International Congress

    Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

    M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: We tested whether inter- and intra-individual differences in clinical severity are determined by cortical compensation, and not just by basal ganglia dysfunction. Background: Motor…
  • 2023 International Congress

    Diffuse cerebellar edema in acute anti-Yo positive paraneoplastic cerebellar degeneration: A case report

    T. Dang, K. Vo, U. Ha, Q. Pham, C. Phan, T. Tran (HO CHI MINH, Viet Nam)

    Objective: To report a case of acute anti-Yo positive paraneoplastic cerebellar degeneration (PCD) with atypical brain MRI findings. Background: PCD is a rare disease but…
  • 2023 International Congress

    Clinical Improvement and drastic reduction of Equivalent Dose of Levodopa (LEDD) in an Advanced Parkinson’s Disease Patient after Levodopa/Entacapone/Carbidopa Intestinal Gel (LECIG) Treatment

    G. Tabar Comellas, MI. Morales Casado, JC. Segundo-Rodríguez, N. Lopez Ariztegui (Toledo, Spain)

    Objective: Describe a patient in which after starting continuous infusion of LECIG a large reduction of the LEDD  is achieved. Background: Gastroparesis (GP) is one…
  • 2023 International Congress

    Neuropalliative communication curriculum: A review of the literature and needs assessment

    K. Block, A. Hiller, N. Leavell, S. Sorge (Portland, USA)

    Objective: We aim to improve neuropalliative education in neurology trainees by creating a reproducible didactic curriculum targeting specific communication techniques using case-based sensitive scenarios commonly…
  • 2023 International Congress

    Impact of dopamine replacement therapy on shame in Parkinson’s disease patients

    S. Catalano Chiuvé, D. Benis, A. Zulet, P. Krack, V. Fleury (Geneva, Switzerland)

    Objective: This study aims to investigate the effect of dopaminergic replacement therapy (DRT) on shame using emotional dynamic rating scales during ON and OFF-DRT states.…
  • 2023 International Congress

    Identifying neural biomarkers of motivated behavior in Parkinson’s disease using sensing-capable DBS devices

    N. Provenza, S. Rajesh, N. Diab, S. Reddy, B. Lamichhane, A. Sabharwal, J. Herron, Y. Gazes, C. Le Heron, S. Sheth, N. Vanegas-Arroyave (Houston, USA)

    Objective: To investigate neural correlates of motivated, goal directed behavior within the basal ganglia. Background: Apathy is a common and debilitating complication of Parkinson’s disease…
  • 2023 International Congress

    Presenting the Dystonia Pain Classification System (Dystonia-PCS)

    C. Listik, E. Listik, F. Rolim, D. Portela, S. Lloret, N. Araújo, P. Carvalho, G. Santos, J. Limongi, F. Cardoso, V. Mylius, F. Brugger, A. Fernandes, E. Barbosa, M. Teixeira, H. Ferraz, S. Camargos, R. Nascimento, M. Cunningham, L. Moriyama, S. Lino, F. Vale, J. Lapa, R. Cury, D. Andrade (Sao Paulo, Brazil)

    Objective: To develop a chronic pain (CP) classification and scoring system for dystonia. Background: CP is prevalent in dystonia and significantly impacts patient’s quality of…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley